Prometheus Biosciences In...

NASDAQ: RXDX · Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM

Prometheus Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
PE Ratio
-31.52 -13.78 -22.3
PEG Ratio
-1.46 -0.09 n/a
PS Ratio
656.18 395.96 712.14
PB Ratio
6.61 5.27 -8.97
P/FCF Ratio
-35.47 -19.17 -31.01
P/OCF Ratio
-36.25 -19.51 -31.24
OCF/S Ratio
-18.1 -20.3 -22.8
Debt / Equity Ratio
0.04 n/a -0.08
Quick Ratio
31.04 16.21 3.77
Current Ratio
31.04 16.14 3.77
Asset Turnover
0.01 0.01 0.02
Interest Coverage
n/a -101.98 -13.62
Return on Equity
-0.21 -0.38 0.40
Return on Assets
-0.19 -0.34 -0.66
Return on Invested Capital
-0.2 -0.33 -0.64
Dividend Yield
n/a 0.00 n/a
Payout Ratio
n/a -0.00 n/a
Gross Profit Margin
1.00 1.00 1.00
Net Profit Margin
-20.82 -28.74 -31.94
Pretax Profit Margin
-20.82 -28.83 -25.34
Operating Profit Margin
-21.41 -28.06 -23.6
FCF Margin
n/a n/a n/a
EBITDA Margin
-21.41 -28.06 -23.52